Round Hill Asset Management Buys New Position in Kenvue Inc. $KVUE

Round Hill Asset Management bought a new stake in Kenvue Inc. (NYSE:KVUE) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 38,173 shares of the company’s stock, valued at approximately $620,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. AlphaQuest LLC lifted its stake in shares of Kenvue by 276.0% during the second quarter. AlphaQuest LLC now owns 12,086 shares of the company’s stock valued at $253,000 after buying an additional 8,872 shares during the period. World Investment Advisors acquired a new stake in shares of Kenvue during the second quarter worth $454,000. Arkadios Wealth Advisors grew its position in shares of Kenvue by 14.7% in the second quarter. Arkadios Wealth Advisors now owns 21,165 shares of the company’s stock valued at $443,000 after purchasing an additional 2,717 shares during the period. Spire Wealth Management grew its position in shares of Kenvue by 13.5% in the second quarter. Spire Wealth Management now owns 4,863 shares of the company’s stock valued at $102,000 after purchasing an additional 580 shares during the period. Finally, Assetmark Inc. increased its stake in Kenvue by 32.1% in the second quarter. Assetmark Inc. now owns 108,923 shares of the company’s stock valued at $2,280,000 after purchasing an additional 26,495 shares during the last quarter. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Kenvue Price Performance

Shares of NYSE KVUE opened at $19.11 on Monday. The firm has a market cap of $36.62 billion, a PE ratio of 24.81, a price-to-earnings-growth ratio of 4.38 and a beta of 0.59. The company has a quick ratio of 0.68, a current ratio of 0.96 and a debt-to-equity ratio of 0.66. The business has a 50 day moving average price of $17.72 and a two-hundred day moving average price of $17.50. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $25.17.

Kenvue (NYSE:KVUE) last released its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share for the quarter, topping analysts’ consensus estimates of $0.22 by $0.05. The business had revenue of $3.78 billion during the quarter, compared to the consensus estimate of $3.68 billion. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The business’s quarterly revenue was up 3.2% compared to the same quarter last year. During the same quarter last year, the company earned $0.26 earnings per share. Sell-side analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th were paid a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a yield of 4.3%. The ex-dividend date was Wednesday, February 11th. Kenvue’s dividend payout ratio (DPR) is 107.79%.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. Zacks Research raised Kenvue from a “strong sell” rating to a “hold” rating in a research note on Wednesday, November 26th. Jefferies Financial Group cut shares of Kenvue from a “buy” rating to a “hold” rating and decreased their target price for the stock from $23.00 to $18.00 in a research report on Friday, January 30th. Canaccord Genuity Group upped their price target on shares of Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a research report on Wednesday, February 18th. Barclays boosted their price objective on shares of Kenvue from $17.00 to $18.00 and gave the company an “equal weight” rating in a research note on Monday, November 10th. Finally, Edward Jones downgraded Kenvue from a “strong-buy” rating to a “hold” rating in a report on Monday, November 3rd. Three research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $19.50.

Insider Activity at Kenvue

In other news, Director Jeffrey C. Smith purchased 3,200,000 shares of the stock in a transaction dated Friday, December 12th. The stock was acquired at an average cost of $17.37 per share, for a total transaction of $55,584,000.00. Following the acquisition, the director owned 27,307,632 shares of the company’s stock, valued at $474,333,567.84. The trade was a 13.27% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 1.68% of the company’s stock.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.